Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Stockholders Equity of $3.16 billion for the year ending 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -8.6% in Stockholders Equity from 2024 to 2025.
- This data is from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s annual report (Form 10-K), filed with the SEC on February 18, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.40 billion | Q3 2010: $1.04 billion | Q1 2011: $562.92 million | Q2 2011: $589.09 million | Q3 2011: $539.71 million | Q1 2012: $552.60 million | Q2 2012: $562.84 million | Q3 2012: $597.71 million | Q1 2013: $628.28 million | Q2 2013: $647.95 million | Q3 2013: $656.51 million | Q1 2014: $695.46 million | Q2 2014: $671.82 million | Q3 2014: $670.30 million | Q1 2015: $663.71 million | Q2 2015: $701.70 million | Q3 2015: $704.36 million | Q1 2016: $779.82 million | Q2 2016: $831.35 million | Q3 2016: $867.97 million | Q1 2017: $876.43 million | Q2 2017: $963.50 million | Q3 2017: $1.02 billion | Q1 2018: $1.14 billion | Q2 2018: $1.18 billion | Q3 2018: $1.25 billion | Q1 2019: $1.40 billion | Q2 2019: $1.46 billion | Q3 2019: $1.53 billion | Q1 2020: $1.65 billion | Q2 2020: $1.75 billion | Q3 2020: $1.90 billion | Q1 2021: $2.18 billion | Q2 2021: $2.32 billion | Q3 2021: $2.43 billion | Q1 2022: $2.61 billion | Q2 2022: $2.65 billion | Q3 2022: $2.63 billion | Q1 2023: $3.11 billion | Q2 2023: $3.25 billion | Q3 2023: $3.31 billion | Q1 2024: $3.64 billion | Q2 2024: $3.72 billion | Q3 2024: $3.78 billion | Q1 2025: $3.19 billion | Q2 2025: $3.35 billion | Q3 2025: $3.41 billion.
- Over the full 17 years of available data (2009 to 2025), CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s Stockholders Equity has grown by 130.1%.
- Historical annual values: Fiscal year 2025: $3.16 billion | Fiscal year 2024: $3.46 billion | Fiscal year 2023: $3.60 billion | Fiscal year 2022: $2.98 billion | Fiscal year 2021: $2.53 billion | Fiscal year 2020: $2.11 billion | Fiscal year 2019: $1.63 billion | Fiscal year 2018: $1.32 billion | Fiscal year 2017: $1.05 billion | Fiscal year 2016: $836.77 million | Fiscal year 2015: $733.07 million | Fiscal year 2014: $672.20 million | Fiscal year 2013: $640.98 million | Fiscal year 2012: $600.81 million | Fiscal year 2011: $525.58 million | Fiscal year 2010: $687.42 million | Fiscal year 2009: $1.38 billion.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: